BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 20108251)

  • 1. Interaction of Sedlin with PAM14.
    Liu X; Wang Y; Zhu H; Zhang Q; Xing X; Wu B; Song L; Fan L
    J Cell Biochem; 2010 Apr; 109(6):1129-33. PubMed ID: 20108251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical consequences of sedlin mutations that cause spondyloepiphyseal dysplasia tarda.
    Choi MY; Chan CC; Chan D; Luk KD; Cheah KS; Tanner JA
    Biochem J; 2009 Sep; 423(2):233-42. PubMed ID: 19650763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Sedlin with chloride intracellular channel proteins.
    Fan L; Yu W; Zhu X
    FEBS Lett; 2003 Apr; 540(1-3):77-80. PubMed ID: 12681486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MRG domain of human MRG15 uses a shallow hydrophobic pocket to interact with the N-terminal region of PAM14.
    Zhang P; Zhao J; Wang B; Du J; Lu Y; Chen J; Ding J
    Protein Sci; 2006 Oct; 15(10):2423-34. PubMed ID: 17008723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular recruitment by TSG118 and TSPYL implicates a role for zinc finger protein 106 in a novel developmental pathway.
    Grasberger H; Bell GI
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1421-37. PubMed ID: 15833274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
    Li R; Pei H; Watson DK; Papas TS
    Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEDLIN forms homodimers: characterisation of SEDLIN mutations and their interactions with transcription factors MBP1, PITX1 and SF1.
    Jeyabalan J; Nesbit MA; Galvanovskis J; Callaghan R; Rorsman P; Thakker RV
    PLoS One; 2010 May; 5(5):e10646. PubMed ID: 20498720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRG15 activates the B-myb promoter through formation of a nuclear complex with the retinoblastoma protein and the novel protein PAM14.
    Leung JK; Berube N; Venable S; Ahmed S; Timchenko N; Pereira-Smith OM
    J Biol Chem; 2001 Oct; 276(42):39171-8. PubMed ID: 11500496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nucleolar protein interacts with ribosomal protein S19.
    Maeda N; Toku S; Kenmochi N; Tanaka T
    Biochem Biophys Res Commun; 2006 Jan; 339(1):41-6. PubMed ID: 16289379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
    Zhou D; Chen B; Ye JJ; Chen S
    Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and functional interactions between Daxx and TSG101.
    Muromoto R; Sugiyama K; Yamamoto T; Oritani K; Shimoda K; Matsuda T
    Biochem Biophys Res Commun; 2004 Apr; 316(3):827-33. PubMed ID: 15033475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32.
    Sunayama J; Ando Y; Itoh N; Tomiyama A; Sakurada K; Sugiyama A; Kang D; Tashiro F; Gotoh Y; Kuchino Y; Kitanaka C
    Cell Death Differ; 2004 Jul; 11(7):771-81. PubMed ID: 15031724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing.
    Danen-van Oorschot AA; Voskamp P; Seelen MC; van Miltenburg MH; Bolk MW; Tait SW; Boesen-de Cock JG; Rohn JL; Borst J; Noteborn MH
    Cell Death Differ; 2004 May; 11(5):564-73. PubMed ID: 14765135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERBP, a novel estrogen receptor binding protein enhancing the activity of estrogen receptor.
    Bu H; Kashireddy P; Chang J; Zhu YT; Zhang Z; Zheng W; Rao SM; Zhu YJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):54-9. PubMed ID: 15047147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A yeast two hybrid screen identifies SPATA4 as a TRAPP interactor.
    Duarte DT; Hul S; Sacher M
    FEBS Lett; 2011 Sep; 585(17):2676-81. PubMed ID: 21827752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
    Liu J; Yuan Y; Huan J; Shen Z
    Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.
    de Bruijn DR; van Dijk AH; Willemse MP; van Kessel AG
    Oncogene; 2008 Jan; 27(5):653-62. PubMed ID: 17667940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TdT interacting factor 1 enhances TdT ubiquitylation through recruitment of BPOZ-2 into nucleus from cytoplasm.
    Hayano T; Koiwai K; Ishii H; Maezawa S; Kouda K; Motoyama T; Kubota T; Koiwai O
    Genes Cells; 2009 Dec; 14(12):1415-27. PubMed ID: 19930467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
    Lee J; Rhee BK; Bae GY; Han YM; Kim J
    Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct binding of TReP-132 with TdT results in reduction of TdT activity.
    Fujisaki S; Sato A; Toyomoto T; Hayano T; Sugai M; Kubota T; Koiwai O
    Genes Cells; 2006 Jan; 11(1):47-57. PubMed ID: 16371131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.